NASDAQ:CNSP | Cash Flow Statement | CNS Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.59M
2026-03-31-$4.94M-$4.65M$6,179.00-$6,179.00$404,660.00
2025-12-31-$5.96M-$3.05M$406,872.00
2025-09-30-$3.22M
2025-06-30-$2.38M
2025-03-31-$4.3M-$3.24M$0.00$0.00$9.83M
2024-12-31-$3.18M-$5.47M$4,188.00-$4,188.00$4.96M
2024-09-30-$5.61M
2024-06-30-$2.53M
2024-03-31-$3.54M-$3.19M$3.46M
2023-12-31-$5.38M-$2.54M$2,157.00-$2,157.00$2.18M
2023-09-30-$4.52M
2023-06-30-$4.02M
2023-03-31-$4.93M-$4.82M-$120,284.00
2022-12-31-$5.14M-$2.31M-$1.00$1.00$5.33M
2022-09-30-$3.42M
2022-06-30-$3.57M
2022-03-31-$3.15M-$3.08M$0.00$0.00$10.51M
2021-12-31-$3.25M-$3.24M$2,076.00-$2,076.00-$82,828.00
2021-09-30-$3.81M
2021-06-30-$3.81M
2021-03-31-$3.61M-$3.31M$3,672.00-$3,672.00$347,432.00
2020-12-31-$3M-$1.45M$0.00$0.00$14.18M
2020-09-30-$2.01M
2020-06-30-$2.47M
2020-03-31-$1.97M-$1.86M$6,410.00-$6,410.00$0.00
2019-12-31-$2.53M-$2.48M$11,743.00-$11,743.00$8.83M
2019-09-30-$706,655.00
2019-06-30-$431,707.00
2019-03-31-$211,501.00-$82,688.00$0.00$0.00-$48,025.00
2018-12-31-$6.63M-$159,493.00$0.00$0.00$6,000.00
2018-09-30-$193,204.00
2018-06-30-$257,483.00
2018-03-31-$309,699.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$15.85M-$13.81M$18,175.00-$18,175.00$14.57M
2024-12-31-$14.86M-$17.11M$4,188.00-$4,188.00$23.03M
2023-12-31-$18.85M-$14.14M$3,901.00-$3,901.00$4.64M
2022-12-31-$15.27M-$10.56M$4,422.00-$4,422.00$15.61M
2021-12-31-$14.5M-$13.54M$5,748.00-$5,748.00$4.51M
2020-12-31-$9.46M-$7.32M$17,945.00-$17,945.00$14.13M
2019-12-31-$3.88M-$3.55M$20,120.00-$20,120.00$10.26M
2018-12-31-$7.39M-$716,385.00$0.00$0.00$1.16M